Help Advance a Potential New Vaccine for RSV!

Researchers in Milford, CT are looking for healthy adults 60 and older to participate in a clinical trial to determine the safety and effectiveness of an investigational respiratory syncytial virus (RSV) vaccine. Participants may be compensated for reasonable travel-related expenses such as parking and meals.

You or someone you may know may qualify if you/they:

Are 60 years of age or older

Are in generally good health

Do not have a history of severe side effects from or allergic reactions to vaccines

There are other qualifications needed for participation in this study. Study staff will discuss them with you after you apply.

See if you qualify!
 
 
What is Respiratory Syncytial Virus (RSV)?

Respiratory syncytial virus is the second most common respiratory illness in adults behind the flu. Although most people who get RSV will have mild, cold-like symptoms, it can be more serious for babies, the elderly, and those with weakened immune systems. Severe RSV can lead to pneumonia or worsened symptoms of chronic obstructive pulmonary disease (COPD) or congestive heart failure (CHF). We are conducting this study to see if an investigational vaccine can help produce antibodies and cells to fight off RSV infections in older adults.

By taking part in this clinical trial, you can help advance vaccines across the globe. Your participation represents your community as well as all people who are affected by RSV.

What is a Clinical Trial?

A clinical research trial tests the safety and effectiveness of a new medicine or treatment in a population of volunteers. Every medical breakthrough goes through the clinical trial process. Therefore, participants like you play a very important role in advancing medicine for present and future generations.

Clinical Research Consulting, LLC
2080 Bridgeport Avenue
Milford, CT 06460
844-247-4475
www.clinicalrc.com